Signs and Symptoms, Digestive  >>  Symproic (naldemedine)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Symproic (naldemedine) / Shionogi, Collegium Pharma
NCT01965158 / 2013-002241-11: Efficacy and Safety of Naldemedine in the Treatment of Opioid-induced Constipation

Completed
3
547
US, Europe
Naldemedine, S 297995, Symproic®, Placebo
Shionogi
Opioid-induced Constipation
01/15
01/15
NCT01993940 / 2013-002948-91: Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation

Completed
3
553
US
Naldemedine, S-297995, Symproic®, Placebo
Shionogi
Opioid-induced Constipation
06/15
06/15
NCT01965652 / 2013-002949-11: Long Term Safety of Naldemedine

Completed
3
1246
US, Canada, Europe, RoW
Naldemedine, S-297995, Symproic®, Placebo
Shionogi
Opioid-induced Constipation
01/16
01/16

Download Options